SOCRA 2024 Annual Conference Program Book - Flipbook - Page 34
FRIDAY, SEPTEMBER 27, 2024
BREAKOUT SESSIONS
TRACK 3: PATIENT ENGAGEMENT
PAVILION 3
Moderator: Catherine Hudson, MPH, CCRC, CCRP
Fri., Sept. 27 1:15 to 2:00 Track: Patient Engagement
Patient Engagement in Orphan Drug Research
A rare-disease patient engagement framework is
proposed to meaningfully collect patient input and
experience to build upon real-world evidence,
compensate for evidence uncertainties, and, ultimately,
support decision-makers in their funding procedures.
309
Presenter: Nahya Awada, PhD, MSCR, CCRP, Senior Research
Program Manager, Calian Health
Fri., Sept. 27 2:05 to 2:50 Track: Patient Engagement
The Importance of Engaging Young People in Research
Mr. Hashemian will discuss patient-centricity in clinical
research, emphasizing the need to prioritize the wellbeing and perspectives of patients throughout the
research process. We will discuss the practical
implementation of patient-centric strategies, such as
leveraging technology for patient-centric data collection,
and fostering collaborations between patients,
investigators, and sponsors. 311
Presenter: Lorraine Hodsdon, BSc, MSc, RN, Head of Nursing
Research and Innovation, NIHR GOSH Clinical Research
Facility
Fri., Sept. 27 3:25 to 4:10 Track: Patient Engagement
Why Minorities Fail to be Recruited in Early Trials
Mr. Young will discuss reasons for reduced trial
partiipation among diverse population. He will also
outline mechanisms/strategies to increase clinical trial
participation among minority ethnic participants. 313
Presenter: Michael Young, Co-Founder, Lindus Health
Fri., Sept. 27 4:15 to 5:00 Track: Patient Engagement
Development of a Process to Share Plain Language
Summaries of Research Results with Participants
Sharing of clinical research results with participants who
contribute to the research helps promote inclusivity and
transparency by making scientific information more
accessible. At Princess Margaret Cancer Centre, feedback
received from a survey of over 500 of our clinical trial
participants indicated that the top factor influencing
their decision to participate in future studies was
obtaining the overall research results. 315
Presenter: Katherine Zeman, BSc, MSc, CCRP, Patient
Engagement & Education Specialist, University Health
Network
- 34 -
TRACK 4: ENROLLMENT, RETENTION,
INFORMED CONSENT
PAVILION 4
Moderator: Allie Mossing, MS, CCRP
Fri., Sept. 27 1:15 to 2:00
Track: Enrollment / ICF
Racial and Ethnic Disparity in Clinical Trial
Enrollment: How to Quantify the Problem and
Implement Tangible Solutions to Solve It
Ms. Fitzpatrick will consider a study to explore disparities
in clinical trial participation that examined both
qualitative and quantitative data to better understand
participant demographics, barriers to participating in
CTs, and the recommendations for actionable solutions
to improve enrollment diversity. 409
Presenter: Veronica Fitzpatrick, DrPH, MPH, BS, Research
Scientist, Advocate Health
Fri., Sept. 27 2:05 to 2:50 Track: Enrollment / ICF
Medical Misinformation in the Media and the
Challenges It Causes in Patient Treatment and
Clinical Trials
Dr. Horvath will review some of the significant historical
cases where data fabrication caused misinformation
which first mislead reviewers then following publication,
the general public. 411
Presenter: Peter Horvath, PhD, CCRP, CRA, Trial Specialist,
University of California, Irvine
Fri., Sept. 27 3:25 to 4:10
Track: Enrollment / ICF
The Fundamentals of the Prescreening Process
Ms. Royse will discuss subject recruitment strategies and
a step-by-step process that includes the creation and
maintenance of a patient database, weekly prescreening
logs, and preparing for the first subject screening. 413
Presenter: Martha Royse, BSN, MSN, RN, APRN, FNP, CCRP,
Owner, Optimal Trial Screening, LLC
Fri., Sept. 27 4: 15 to 5:00
Track: Enrollment / ICF
Rolling out the Red Carpet for Research Recruitment
In the ever-evolving world of technology, human
interaction is centrally important to the informed
consent process. From the study design level all the way
to the conduct of patient engagement, adjustments and
tactics learned managing investigator-initiated studies at
an academic medical institution can yield increased
engagement and create a lasting impact on the research
participant experience. 415
Presenter: Samantha Eldersveld, BA, CCRP, Clinical Research
Project Manager, Nationwide Children's Hospital
